Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03777098 · ClinicalTrials.gov registry record
Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis
A clinical trial of Group A Streptococcal Infection, sponsored by David A. Talan.
- Completed
- Registry status
- 426
- Enrollment target
- 1
- Study location
NCT03777098 is a study of Group A Streptococcal Infection that has completed, run by David A. Talan. The registered enrollment target is 426 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03777098, a study of Group A Streptococcal Infection, has completed, sponsored by David A. Talan.
- COMPLETED
- Registry status
- 426 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this pilot study is to acquire images using the Strepic® device, a clinical prototype that has been designed specifically as a viable, low-cost, commercially realizable autofluorescence-based diagnostic test, using (1) fluorescence and (2) white light image data, as well as other clinical data points. By acquiring and analyzing the images of pharyngeal bacterial fluorescence and white light patterns in patients with Group A Streptococcus (GAS)-associated pharyngitis and comparing them with those observed in non-GAS pharyngitis, it is believed an algorithm can be developed such that the device will improve the ability of clinicians to quickly and accurately identify GAS infections.
Conditions Studied
Interventions
- DEVICE Strepic® Device
Study Locations (1)
California
- Olive View-UCLA Medical Center - Sylmar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 426 participants |
| Start Date | 2019-01-02 |
| Est. Completion | 2021-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03777098
The ClinicalTrials.gov registry entry for NCT03777098 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 426 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David A. Talan, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Group A Streptococcal Infection appearing as the primary indexed condition, and to 1 intervention - of which Strepic® Device is the first listed.
NCT03777098 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03777098 about?
NCT03777098 is a clinical study titled "Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis". The objective of this pilot study is to acquire images using the Strepic® device, a clinical prototype that has been designed specifically as a viable, low-cost, commercially realizable autofluorescence-based diagnostic test, using (1) fluorescence and (2) white light image data, as well as other cl...
What is the current status of trial NCT03777098?
This trial is currently completed. The enrollment target is 426 participants. The study started on 2019-01-02. Estimated completion is 2021-12-30.
What conditions does trial NCT03777098 study?
This clinical trial studies the following conditions: Group A Streptococcal Infection.
What interventions are being tested in trial NCT03777098?
The interventions under investigation include: Strepic® Device (DEVICE).
Who is sponsoring clinical trial NCT03777098?
This trial is sponsored by David A. Talan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03777098 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Group A Streptococcal Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.